New Medication Effectively Treats Underlying Cause Of Cystic Fibrosis
Originally posted in Cystic Fibrosis News From Medical News Today
A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, “A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation,” led by Bonnie W…
No Comments »
RSS feed for comments on this post. TrackBack URL
by Raelene
